针对细菌性阴道炎的双益生菌和抗生素治疗:一个集成的实验/计算建模视角
Bassam Fotouh1, Anthony J Kyser1, Mohamed Y Mahmoud1,2
1Department of Bioengineering, University of Louisville, Louisville, KY, USA.
Biomedical engineering advances
|June 18, 2025
概括
一个新的3D打印的支架提供了美特罗尼达和Lactobacillus crispatus来治疗细菌性阴道炎 (BV). 这种综合方法有效地抑制病原体,同时恢复有益细菌,为个性化BV疗法铺平了道路.
科学领域:
- 微生物学 微生物学
- 生物医学工程 生物医学工程
- 计算生物学 计算生物学
背景情况:
- 细菌性阴道炎 (BV) 是一种常见的阴道微生物组失衡.
- 目前的治疗方法可能会破坏有益的植物群.
- 新的策略旨在恢复微生物的平衡,并改善粘附.
研究的目的:
- 开发和评估一个集成的实验和计算平台,以评估细菌性阴道炎 (BV) 的双重治疗策略.
- 通过模拟3D打印支架的药物和益生菌释放来设计针对BV的个性化治疗方法.
- 在不同的营养条件下,研究致病性 (Gardnerella) 和有益 (Lactobacillus crispatus) 细菌之间的相互作用.
主要方法:
- 在体外实验中评估了细菌生长,葡萄糖消耗,乳酸生产和pH值.
- 一个计算模型模拟了阴道条件,营养动态,细菌相互作用和双重药物/益生菌释放.
- 敏感性分析评估了不同度的抗生素和益生菌.
- 结果与3D打印脚手架的实验数据进行了验证.
主要成果:
- 在低葡萄糖度下,Lactobacillus crispatus超过了Gardnerella的竞争力;在高葡萄糖度下,Gardnerella占据主导地位.
- 计算机建模预测,双重疗法可以抑制加德内拉菌和促进L. crispatus,即使在较低的剂量.
- 模拟的双重治疗增加了乳酸的产生,降低了阴道pH值,有利于有益的微生物群.
结论:
- 一个集成的实验/计算建模方法有效评估细菌相互作用和BV的治疗策略.
- 这个平台可以设计个性化的BV治疗方法,消除病原体并恢复有益的微生物群.
- 3D打印的支架为双重疗法提供了一个有前途的持续释放输送系统.
相关概念视频
Antibiotic Selection
55.4K
Overview
55.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
561
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
561
Microorganisms in Medicine and Therapeutics
382
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
382


